TVB-2640
22-08025117
Phase 1 small_molecule active
Quick answer
TVB-2640 for Prostatic Neoplasms, Castration-Resistant is a Phase 1 program (small_molecule) at Sagimet Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sagimet Biosciences
- Indication
- Prostatic Neoplasms, Castration-Resistant
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active